author-photo

Patricia Pautier

Institut Gustave Roussy

493

Papers

8869

Citations

Citation Trend

Filter By

Papers (344) Sort By

Journal Conference Others

801P Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cervical Cancer and Fertility-Sparing Treatment

2021 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (0)
956 Retifanlimab (INCMGA00012) in patients with recurrent MSI-H or dMMR endometrial cancer: results from the POD1UM-101 study

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
ASO Visual Abstract: Brenner Borderline Ovarian Tumor-A Case Series and Literature Review

2021 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Optimal treatment duration of bevacizumab (BEV) combined with carboplatin and paclitaxel in patients (pts) with primary epithelial ovarian (EOC), fallopian tube (FTC) or peritoneal cancer (PPC): A multicenter open-label randomized 2-arm phase 3 ENGOT/GCIG trial of the AGO Study Group, GINECO, and NSGO (AGO-OVAR 17/BOOST, GINECO OV118, ENGOT Ov-15, NCT01462890).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Surgery for recurrent ovarian cancer: expert point of view

2021
Show All
- Source
- Cite
- Save
Citations (0)
947 Results after conservative surgery of stage II/III serous borderline ovarian tumors

2021
Show All
- Source
- Cite
- Save
Citations (0)
741P Immune features of high-grade ovarian cancer associated with exceptional disease free survival (DFS): An analysis from VIVROVAIRE, a GINECO/GINEGEPS study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (1)
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

2021
Show All
- Source
- Cite
- Save
Citations (2)